OpenAlex
PricingAboutJobs
Log inGet started
Work

Inhibition of HIV-1 capsid assembly: Optimization of the antiviral potency by site selective modifications at N1, C2 and C16 of a 5-(5-furan-2-yl-pyrazol-1-yl)-1H-benzimidazole scaffold

HTML

Year: 2012
Type: article
Source: Bioorganic & Medicinal Chemistry Letters
DOI: 10.1016/j.bmcl.2012.10.034
Authors: Martin Tremblay, Pierre Bonneau, Yves Bousquet, Patrick DeRoy, Jianmin Duan, Martin Duplessis, Alexandre Gagnon, Michel Garneau, Nathalie Goudreau, Ingrid Guse, Oliver Hucke, Stephen H. Kawai, Christopher T. Lemke, Stephen W. Mason, Bruno Simoneau, Simon Surprenant, Steve Titolo, Christiane Yoakim
Institutions: Boehringer Ingelheim (Canada), Université du Québec à Montréal, Bristol-Myers Squibb (United States)
Language: English

Topic: HIV/AIDS drug development and treatment
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Keywords: capsid assembly inhibitors, site-selective modification, X-ray crystal structure, high-throughput screening hits
SDG: Good health and well-being

Open Access status: closed

Funder: World Health Organization
OpenAlex ID: W2015037490
FWCI: 2.007
Cites: 23
Cited by: 37
Related to: 8
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security